Abstract
H ealthcare expenditure as a proportion of gross domestic product (GDP) continues to increase in the US, Europe and Japan for a number of reasons. Government initiatives to contain healthcare spending, and the implications for the pharmaceutical industry, were the focus of a seminar organised by Management Forum entitled ‘Cost containment and its impact’ [ London, UK; Jun 1994 ].
Rights and permissions
About this article
Cite this article
Winter, S. Cost containment policies - can the industry survive?. Pharmacoecon. Outcomes News 10, 3–4 (1994). https://doi.org/10.1007/BF03289802
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03289802